A marked increase in concomitant autoimmune diseases has previously been noted in patients with myasthenia gravis (MG). We show that these diseases occur both before and after the onset of MG and that the process is not influenced by thymectomy. IgA deficiency (IgAD), which is strongly associated with the same HLA haplotype as early onset MG, has recently been suggested to be an autoimmune disease. However, there was no increase in the prevalence of IgAD in a large cohort of Swedish MG patients.
Introduction
Myasthenia gravis (MG) is an antibody mediated autoimmune disorder, characterized by auto-antibodies against the nicotinic acetylcholine receptor (anti-AChR antibodies), situated on the muscle end-plate, that impair transmission of nerve impulses to the muscle. MG occurs in approximately 1 in 10,000 individuals in European populations and has a concordance rate of 30-40% in monozygotic twins (Lisak, 1994) , indicating a strong genetic component. Several genetic loci have previously been shown to be associated with MG, including PTPN22, IL-1, TNF-α, and the MHC, in particular the B8, DR3 haplotype in early onset MG and the B7, DR2 haplotype in late onset MG (Giraud et al., 2008) .
MG often occurs concomitantly with other autoimmune disorders, including rheumatoid arthritis (RA) (Christensen et al., 1995) , Type I diabetes (TID) (Toth et al., 2006) , thyroid disorders (Graves' disease) (Sahay et al., 1965; Monden et al., 1986; Christensen et al., 1995; Marinó et al., 1997; Kanazawa et al., 2007) and systemic lupus erythematosus (SLE) (Vaiopoulos et al., 1994; Mevorach et al., 1995; Hrycek, 2009; Omar et al., 2010) . In a long term study in Denmark, autoimmune disorders were concomitant with MG in 14% of cases, the most common being RA and thyroid disorders (Christensen et al., 1995) . SLE has been reported in over 50 MG cases in the literature (Bhinder et al., 2006) . Similar genetic associations, overlapping with other autoimmune conditions, including the HLA-B8, DR3 haplotype and the R620W variant of PTPN22, suggest that common mechanisms may exist which predispose MG patients for additional autoimmune disorders. However, it cannot be excluded that immunosuppressive treatment in MG, including thymectomy, disturbs the balance of immunity, leading to additional disorder(s) (Zonana et al., 2002) .
Selective IgA deficiency (IgAD) is defined as serum IgA levels less than 0.07 g/l with normal levels of IgM and IgG. Its prevalence of 1 in 600 in European populations makes it the most common form of primary immunodeficiency (Hammarström and Smith, 2007) . A high rate of familial incidence and a high relative risk for siblings indicate a strong genetic predisposition. The extended HLA-A1, B8, DR3, DQ2 haplotype has been shown to be strongly associated with IgAD, occurring in 45% of patients in Sweden (Mohammadi et al., 2008) . This haplotype has also been shown to be associated with several autoimmune diseases, including TID (Smith et al., 1978) , celiac disease (CD) (Congia et al., 1994) , SLE (Skarsvåg et al., 1992) and Graves' disease (Farid et al., 1976) , and an overrepresentation of IgAD among patients with these disorders has previously been observed (Ammann and Hong, 1971; Ryser et al., 1988; Jorgensen et al., 2009) . Recently, it has even been suggested that IgAD might itself be autoimmune in nature (Ferreira et al., 2010) .
Although MG is associated with the B8, DR3, DQ2 haplotype, previous studies, in small sized materials (b110 patients), have not shown an increase in the prevalence of IgAD in MG patients (Bramis et al., 1976; Lisak and Zweiman, 1976; Wetherall et al., 1976; Liblau et al., 1992) . The single large scale study published to date screened 333 patients, and found only one to be IgAD (Liblau et al., 1992) . However, another study did observe a decrease in serum IgA in 13 of 51 MG patients as compared to 4 of 51 controls (Behan et al., 1976) .
In view of the inconclusive data obtained so far, we sought to determine if an increased incidence of IgAD occurs in MG by testing Journal of Neuroimmunology 236 (2011) 118-122 
